JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Arbor Realty Trust (ABR) Announces 5.5M Share Common Offering
-
Arbor Realty Trust, Inc. Announces Public Offering of Common Stock
-
Tufin Named One of Hottest Privately Held Cybersecurity Companies
-
SQZ Biotech CEO to Participate in BIO International Panel and to Present at Investor Conferences in Second Quarter 2018
-
Fortress Biotech Appoints Michael G. King, Jr. as Entrepreneur in Residence
-
Fortress Biotech Appoints Michael G. King, Jr. as Entrepreneur in Residence
-
JMP Securities Downgrades Maiden Holdings (MHLD) to Market Perform
-
PennyMac Mortgage Investment Trust (PMT) PT Raised to $19 at JMP Securities
-
AxoGen, Inc. Announces Closing of Public Offering of Common Stock
-
AxoGen, Inc. Announces Closing of Public Offering of Common Stock
-
JMP Securities Starts MorphoSys AG (MOR) at Market Outperform
-
Sabra Healthcare REIT Inc. (SBRA) PT Raised to $21 at JMP Securities
-
Pegasystems (PEGA) PT Raised to $72 at JMP Securities
-
Carvana (CVNA) PT Raised to $35 at JMP Securities
-
Evelo Biosciences Announces Closing of Initial Public Offering
-
Evelo Biosciences Announces Closing of Initial Public Offering
-
Avalara Files Registration Statement for Proposed Initial Public Offering
-
JMP Securities Downgrades Mattersight Corp (MATR) to Market Perform Citing Valuation
-
Aclaris Therapeutics to Attend Upcoming Investor Conferences
-
Hercules Announces Upcoming Events for Financial Community
-
JMP Securities Downgrades SolarEdge Technologies (SEDG) to Market Perform Citing a Full Valuation
-
Wix.com (WIX) PT Raised to $96 at JMP Securities
-
STERIS (STE) PT Raised to $113 at JMP Securities
-
argenx SE (ARGX) PT Raised to $93 at JMP Securities
-
Sunrun (RUN) PT Raised to $15 at JMP Securities; 'Competitive Lead Continues to Widen'
-
Alteryx (AYX) PT Raised to $37 at JMP Securities; 'Sixth Quarter in a Row of 130% Plus Retention Rates'
-
JMP Securities Downgrades New Relic (NEWR) to Market Perform
-
Evelo Biosciences (EVLO) IPO Opens Flat
-
Proteon Therapeutics Announces First Quarter 2018 Financial Results
-
Aimmune Therapeutics to Participate in Four Upcoming Investor Conferences in May and June
-
AxoGen (AXGN) Prices Upsized 3M Share Offering at $41
-
AxoGen, Inc. Announces Upsizing and Pricing of Public Offering of Common Stock
-
AxoGen, Inc. Announces Upsizing and Pricing of Public Offering of Common Stock
-
Evelo Biosciences (EVLO) Prices 5.31M Share IPO at $16/Sh
-
Marlin Business (MRLN) PT Raised to $34 at JMP Securities; '1Q18 Follow-up:Beginning to Monetize the Flow'
-
Model N, Inc. (MODN) PT Raised to $25 at JMP Securities
-
Motorola Mobility Holdings (MMI) PT Raised to $41 at JMP Securities
-
LGI Homes (LGIH) PT Raised to $84 at JMP Securities
-
Haemonetics (HAE) PT Raised to $90 at JMP Securities; 'Now Pivoting to Accelerating Growth Stage'
-
Extreme Networks (EXTR) PT Lowered to $14 at JMP Securities
-
Cornerstone OnDemand (CSOD) PT Raised to $60 at JMP Securities
-
Loxo Oncology (LOXO) PT Raised to $152 at JMP Securities
-
Twilio (TWLO) PT Raised to $55 at JMP Securities; 'Revenue Growth and Gross Margins Beat Expectations'
-
Zillow Group (ZG) PT Raised to $60 at JMP Securities
-
Evelo Biosciences Announces Pricing of Initial Public Offering
-
Evelo Biosciences Announces Pricing of Initial Public Offering
-
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2018
-
Lattice Engines and Engagio Announce Strategic Partnership to Create Personalized and Scalable ABM Programs
-
Nevro Corp (NVRO) PT Lowered to $105 at JMP Securities
-
Equity Commonwealth (EQC) PT Raised to $34 at JMP Securities; 'Demonstrating Little Desire to Acquire'

